Litigation

Recent Posts

N.J. Risperdal Jury Finds Diabetes Warning Lacking, But Drug Didn't Cause Disease
Posted on 17 Feb 2012 by Tom Moylan

NEW BRUNSWICK, N.J. - (Mealey's) A Risperdal personal injury trial ended Feb. 16 in a defense verdict for Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. after a New Jersey state court jury found that Janssen failed to warn about the... Read More

Tags: Gary D. Skala , drugs , Risperdal , et al. , Johnson , personal injury , AstraZeneca , New Jersey , Gary D. Skala v. Johnson &amp , Litigation , amp , mass tort , Eli Lilly and Co. , Zyprexa , verdict , diabetes , Seroquel , Janssen Pharmaceuticals , Johnson &amp , antipsychotic drug